| Schedule of Basic Earnings Per Share |
The following table presents the basic earnings per share (“EPS”) for a share of Class A common stock: | | | | | | | | | | | | | | | | | | | | | Year Ended March 31, | | | | 2026 | | 2025 | | 2024 | | | | | | | | | | | | Net income attributable to HLI | $ | 249,180 | | | $ | 217,417 | | | $ | 140,858 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Weighted Average Shares | 41,605,636 | | | 39,922,212 | | | 37,858,177 | | | | | Basic EPS of Class A common stock | $ | 5.99 | | | $ | 5.45 | | | $ | 3.72 | | | |
|
| Schedule of Diluted Earnings Per Share |
The following table presents the diluted EPS for a share of Class A common stock: | | | | | | | | | | | | | | | | | | | Year Ended March 31, | | 2026 | | 2025 | | 2024 | | Numerator | | | | | | | Net income attributable to Class A common stockholders - basic | $ | 249,180 | | | $ | 217,417 | | | $ | 140,858 | | Adjustments to net income: | | | | | | | Assumed vesting of employee awards | 567 | | | 544 | | | 90 | | | | | | | | | Assumed conversion of Class B and Class C units | 72,665 | | | — | | | 58,209 | | Net income attributable to Class A common stockholders | $ | 322,412 | | | $ | 217,961 | | | $ | 199,157 | | | Denominator | | | | | | | Weighted-average shares of Class A common stock outstanding - basic | 41,605,636 | | | 39,922,212 | | | 37,858,177 | | | Assumed vesting of employee awards | 421,111 | | | 385,606 | | | 82,742 | | | | | | | | | Assumed conversion of Class B and Class C units | 12,442,646 | | | — | | | 15,961,548 | | Weighted-average shares of Class A common stock outstanding | 54,469,393 | | | 40,307,818 | | 53,902,467 | | Diluted EPS of Class A common stock | $ | 5.92 | | | $ | 5.41 | | | $ | 3.69 | |
|
| Schedule of Weighted-Average Shares Excluded from Calculation of Diluted Earnings Per Share |
The following table presents the weighted-average Performance Awards and the Warrant shares excluded from diluted EPS that would have been antidilutive or for which the market or performance conditions have not been achieved as of the period reported: | | | | | | | | | | | | | | | | | | | | | Year Ended March 31, | | | | 2026 | | 2025 | | 2024 | | | Performance Awards | 1,346,727 | | 774,359 | | 528,282 | | | | Warrant Shares | 99,726 | | — | | — | | | | Outstanding Class B and C units of HLA | — | | | 14,016,324 | | | — | | | |
|